Screening for anti-inflammatory components from  Turcz. based on macrophage binding combined with HPLC by unknown
RESEARCH ARTICLE Open Access
Screening for anti-inflammatory components
from Corydalis bungeana Turcz. based on
macrophage binding combined with HPLC
Zi-Bo Dong1,2*, Yong-Hong Zhang2, Bing-Jie Zhao2, Chao Li3, Gang Tian3, Ben Niu3, Hong Qi3, Liang Feng1*
and Jian-Guo Shao3
Abstract
Background: Corydalis bungeana Turcz. (CB; family: Corydalis DC.) is an anti-inflammatory medicinal herb used
widely in traditional Chinese medicine (TCM) for upper respiratory tract infection, etc., but its anti-inflammatory
active molecules are unknown. This study was designed to screen for the anti-inflammatory components from CB
based on macrophage binding combined with HPLC.
Methods: Xylene-induced ear edema in mouse and carrageenan-induced hind-paw edema in rats were used to
evaluate the anti-inflammatory activity of CB. The macrophage binding with high-performance liquid chromatography
(HPLC) analysis and HPLC-MS were established to screen the potential active compounds. ELISA kits were performed to
measure the levels of IL-6, IL-10, TNF-α and NO in RAW 264.7 macrophages culture media.
Results: The alkaloid extract of CB could inhibit significantly xylene-induced ear edema in mouse and
carrageenan-induced hind-paw edema in rats. Two components binded to RAW 264.7 cell were identified
as 12-hydroxycorynoline and corynoline. Bioassays demonstrated that these two compounds significantly
inhibited LPS-induced IL-6, IL-10, TNF-α and NO levels.
Conclusions: The results suggest that corynoline and 12-hydroxycorynoline contribute to the anti-inflammatory
effects of the alkaloid extract of CB. Our findings suggest that these two compounds can be used as candidate for
anti-inflammatory drugs.
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Background
Corydalis bungeana Turcz. (CB; family: Corydalis) is a
perennial herb containing several pharmacologically im-
portant alkaloids such as corydaline, 12-hydroxycorynoline,
protopine, acetylcorynoline, and corynoline [1]. The dried
whole plant is referred in traditional Chinese medicine
(TCM) as Herba Corydalis Bungeanae, clearing heat and
toxins, as well as anti-inflammatory [2]. Corynoline is the
major alkaloid component derived from CB. It has been
known that corynoline, acetylcorynoline, and protopine can
significantly reduce carbon tetrachloride (CCl4)-induced
microsomal lipid peroxidation [3] and attenuate two, 4-
dinitro-1-fluorobenzene-induced delayed-type hypersensi-
tivity [2]. Some isoquinoline alkaloids such as 12-
hydroxycorynoline isolated from CB have bacteriostatic
activity [4]. CB has been used for treating influenza, infec-
tions of the upper respiratory tract, bronchitis, tonsillitis,
acute nephritis, and pyelonephritis [5]. However, the mole-
cules responsible for treating inflammatory diseases have
not been identified.
Extraction and purification of compounds from herbs
is time-consuming. Screening of bioactive compounds
for use in animal models of disease is also laborious
and inappropriate for TCMs [6]. The action of drugs is
usually demonstrated a fact that the drug molecules
interacted with receptors, enzymes or channels on cell
membranes, and then mediated signaling cascade [7]. A
screening method involving in the binding of molecules
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to the membranes of human red blood cells and high-
performance liquid chromatography (HPLC) analysis was
developed to identify the active components of herb ex-
tract [8]. Here, we report an improved method based on
macrophage binding and HPLC. Cell suspensions were
treated with the alkaloid extract of CB and then centri-
fuged to remove unbound components. The final eluate
was collected as a sample for screening potential active
components in medicinal herbs by HPLC analysis.
Lipopolysaccharide (LPS) is an endotoxin and a con-
stituent of the outer membrane of Gram-negative bac-
teria [9]. LPS-stimulated macrophages can produce
various inflammatory mediators: interleukins (such as
IL-6, IL-8, etc.), interferon (IFN)-γ and TNF-α [10].
Levels of inflammatory mediators in the supernatants
of LPS-stimulated macrophages are reliable markers
of inflammation. Various chemicals in plants show
anti-inflammatory activity by modulating levels of
inflammation-associated genes and inhibiting the re-
lease of inflammation-associated mediators. Hence,
stimulation of macrophages with LPS offers an ex-
cellent model for screening and subsequent evalu-
ation of the inflammatory effects of candidate drugs.
In this study, we screened the components from the ex-
tract of CB and then evaluated the effects of components
screened from the alkaloid extract of CB using LPS-
stimulated RAW 264.7 cells (a macrophage cell line) by
examining cytokine production.
Methods
Plant materials and reagents
The samples of CB were purchased from Anhui Pharma-
ceutical Company (An’hui, China; voucher specimen ID
number: 20120425). Botanic identification was con-
firmed by Professor Chungen Wang (Nanjing University
of Chinese Medicine, Nanjing, China). Specimens are
stored in the Herbal Specimens Center of Jumpcan
Pharmaceuticl Co.,Ltd (Stored specimen No. JC-2012-
005). Protopine, 12-hydroxycorynoline, 6-acetonylcory-
noline, corynoline and acetylcorynoline were prepared
by the Nanjing University of Chinese Medicine and pur-
ity was 99 % according to HPLC analysis. Aspirin was
obtained from Nanjing Baijingyu Pharmaceutical Co., Ltd.
(Nanjing, China). Xylene was purchased from Shanghai
Qiangshun Pharmaceutical Co., Ltd. (Shanghai, China).
LPS and carrageenan were obtained from Sigma–Aldrich
(Saint Louis, MO, USA). Dulbecco’s modified Eagle’s
medium (DMEM) was purchased from Gibco (Grand
Island, NY, USA). Fetal bovine serum (FBS) was obtained
from Wisent Biological Corporation (Nanjing, China).
Enzyme-linked immunosorbent assay (ELISA) kits for de-
termination of the levels of IL-6, IL-10 and TNF-α were
purchased from eBioscience (San Diego, CA, USA). Kits
for the measurement of nitric oxide (NO) was obtained
from Beyotime Institute of Biotechnology (Shanghai,
China). The murine macrophage cell line (RAW 264.7
cells) was kindly provided by Professor Xu Qiang
(Nanjing University, Nanjing, China). Water for HPLC
analysis was purified using a Milli-Q Water Purifica-
tion system (Millipore, Bedford, MA, USA). Other re-
agents were of analytical grade.
Animals
ICR mice (18–24 g) and Sprague–Dawley (SD) rats
(150–200 g) were purchased from the Zhejiang Ex-
perimental Animal Center (Zhejiang, China). All ani-
mals were maintained at the Nanjing University of
Chinese Medicine under specific pathogen-free condi-
tions. The study protocol was authorized by the Ethics
Committee of Nanjing University of Chinese Medicine
(Nanging, China) in accordance with the Guide for the
Care and Use of Laboratory Animals (National Institutes
of Health, Bethesda, MD, USA).
Extraction and isolation of alkaloids
Air-dried herbs (20 kg) were extracted twice with 200 and
160 l of 60 % (v/v) ethanol (blend 95 % (v/v) ethanol with
appropriate water to 60 %) for 1 h successively. Extracts
were collected and concentrated under reduced pressure
at 55 °C. Concentrates were suspended in water, adding
1 mol/L HCl to adjust pH 2 of the solution, left for 4 h,
then 40 % (v/v) NaOH (40 g NaOH dissolved in 100 ml of
water) mixed with the liquor until its pH 9, left overnight.
Extracts (300 g) were filtered to obtain a fraction of crude
alkaloids and then extracted with a ten-fold volume of
95 % (v/v) ethanol under reflux for 1 h. This extraction
was repeated twice. The extract was collected and con-
centrated under reduced pressure at 55 °C (i.e., 20 g of
alkaloid components with minimum polarity). The resi-
due was extracted with equal volumes of butanol thrice
and combined with butanol. The extract was collected
and concentrated under reduced pressure at 55 °C (i.e.,
alkaloid components with maximum polarity). The
samples (i.e., alkaloid extract of CB) were ready for
HPLC analysis.
Cell culture and binding
RAW 264.7 macrophages were cultured in DMEM sup-
plemented with 10 % FBS, antibiotics (10 U/mL penicillin
G, 100 g/mL streptomycin), and maintained at 37 °C in a
humidified incubator containing 5 % CO2. Cell suspen-
sions (10 mL; 2 × 107 cells) were treated with the alkaloid
extract of CB (0.5 μg/mL) for 1 h at 37 °C. Suspensions
were then centrifuged for 15 min at 1000 rpm (175 × g) at
room temperature and cell pellets were washed for ten
times to remove unbound components. Washed eluates
were discarded except for the final eluate, which was col-
lected as a control for HPLC analysis (sample A). RAW
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264.7 macrophages were denatured by addition of 10 mL
hydrochloric acid and phosphate-buffered saline (PBS;
pH 4.0) to liberate components bound to cells whithout
damaging the physiological state of cells. The desorption
eluate was clarified by centrifugation and retained for
HPLC analysis (sample B). Cells treated with dimethyl
sulfoxide (DMSO) alone were used as the vehicle control
of the alkaloid extract of CB, as the vehicle desorption elu-
ate (sample C). Aliquots (1 mL) of samples A, B and C
were mixed separately with 1 mL methanol, vortex-mixed
for 2 min, and centrifuged at 10,000 rpm for 3 min at
room temperature. Supernatants were collected and dried
under nitrogen at 45 °C. Residues were taken up into
200 μL methanol and filtered through a 0.45-μm nylon
membrane before HPLC analysis.
HPLC analysis
The alkaloid extract of CB and RAW 264.7 macrophage-
bound samples were analyzed by HPLC. We used a Series
1100 Liquid Chromatograph (Agilent Technologies, Palo
Alto, CA, USA) equipped with a vacuum degasser, a qua-
ternary pump, an autosampler and a photodiode-array de-
tector (PDA) connected to Agilent ChemStation software.
A phenomenex Gemini C18 ODS column (4.6 mm×
250 mm, 5 μm) was used. The mobile phase was (A) am-
monium acetate (10 mM; pH 9.5); (B) methanol. The flow
rate was 1 mL/min. The elution conditions were: B, 0–
45 min, linear gradient 15–60 % B; 45–70 min, linear gra-
dient 60–86 % B; 70–80 min, linear gradient 86–15 % B.
The system operated at 30 °C and the injection volume
was 10 μL. The detection wavelength was kept at 289 nm.
HPLC-mass spectrometry (MS) analysis
MS conditions were: positive ion model; drying gas, N2;
spray tip potential, 5290 V; nozzle potential, 140 V; noz-
zle temperature, 140 °C; detector voltage, 2100 V; scan
range, 50–1000 m/z. An Alliance 2690 HPLC instru-
ment (Waters, Milford MA, USA) coupled with a UV
detector was used for quantitative determination. The
chromatographic conditions were as described above.
Chromatograms were monitored at 289 nm. The struc-
ture was confirmed by H-NMR and C13-NMR. (5 mg
sample was dissolved in d6-CDCl3, and detected by
AV-500. BRUKER.)
Evaluation of anti-inflammatory activity in vitro
RAW 264.7 macrophages (1.2 × 106) were cultured in
DMEM supplemented with 10 % FBS and maintained
at 37 °C in a humidified incubator containing 5 %
CO2. Cells were stimulated with LPS (0.5 μg/mL) for
24 h and treated with different concentrations
(100 μg/mL, 10 μg/mL, 1 μg/mL, 100 ng/mL and
10 ng/mL) of compounds obtained from the alkaloid
extract of CB for 1 h. Control values were obtained in
the absence of LPS and compounds. Levels of IL-6, IL-
1β, NO and TNF-α in macrophage culture media were
measured by ELISA kits according to manufacturer’s
instructions.
Xylene-induced ear edema in mice
The xylene-induced ear edema test with modifications
was conducted as described previously [11]. Briefly,
four groups of ten mice were treated (via the oral
route) with physiological (0.9 %) saline (control), alkal-
oid extract of CB (40 and 80 mg/kg) or aspirin
(150 mg/kg; positive control). Mice were co-administrated
(by gavage) with different doses of the alkaloid extract
of CB intragastrically once a day for 5 days. About
1 h after administration, each mouse received 50 μL
of xylene on the inner and outer surfaces of the right
ear. A further 1-h later, ear thickness was measured
with a Thickness Gauge (Harbin Measuring & Cutting
Fig. 1 Anti-inflammatory effect of the alkaloid extract of CB on ear swelling (a) and ear weight (b) in xylene-induced mice. Values are expressed
as mean ± SD (n = 10). *p < 0.05 and **p < 0.01 vs. model group
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Tool Group Co., Ltd., Harbin, China). Mice were
killed by cervical dislocation. Ear biopsies (diameter,
9.0 mm) were punched out and weighed. The degree
of ear swelling was calculated based on the weight
difference between the biopsies of the right and left
ear of the same mouse. Percent inhibition of edema
was calculated using the formula:
Edema inhibition %ð Þ ¼ edemacontrol‐ edemadrugs
 
=edemacontrol  100%
Carrageenan-induced paw edema in rats
The method used for this investigation was similar to that
reported previously [11]. Forty male SD rats were divided
into four groups: model control (saline); alkaloid extract
of CB (30 mg/kg and 60 mg/kg); aspirin (400 mg/kg).
The normal volume of the right hind-paw of each rat
was measured with a Water Displacement Plethysm-
ometer (YLS-7B; YiyanTechnology Co, Ltd, Jinan,
China) after the final administration of extract. Then,
each rat was treated with 0.1 mL of 1 % carrageenan by
subcutaneous injection into the right hind-paw 1 h after
administration. Paw volume was measured again at 0.5,
1 and 3 h after the induction of inflammation. Swelling
volume was calculated as V2–V1, where V1 and V2 are
the right hind-paw volumes (mL) of the first and second
measurements, respectively.
Statistical analysis
Data are expressed as the mean ± SD. Comparisons be-
tween groups were analyzed by one-way ANOVA. Dun-
nett’s test was employed for comparison between two
groups. p < 0.05 was considered significant.
Results
Effect of the alkaloid extract of CB on xylene-induced ear
edema in mice
Utilizing a typical model of inflammatory response
(xylene-induced ear edema), the anti-inflammatory ac-
tivity of the alkaloid extract of CB was investigated.
Fig. 3 HPLC fingerprint of the alkaloid extract of Corydalis bungeana Turcz
Fig. 2 Anti-inflammatory effect of the alkaloid extract of CB on
carrageenan-induced hind-paw edema in rats. Values are expressed
as mean ± SD (n = 10). *p < 0.05 and **p < 0.01 vs. model group
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The alkaloid extract of CB (40 and 80 mg/kg) showed
significant inhibition of xylene-induced mice ear
edema as compared with the control, with inhibition
of 32.1 and 45.1 % (P < 0.01) respectively (Fig. 1).
Effect of the alkaloid extract of CB on carrageenan-
induced hind-paw edema
Carrageenan-induced paw inflammation is an acute and
highly reproducible model of acute inflammatory re-
sponse [12]. Cardinal signs of inflammation develop im-
mediately after subcutaneous injection and result from
action of pro-inflammatory agents. The inflammatory re-
sponse is usually quantified by increase in paw size
(edema) and is modulated by inhibitors within the in-
flammatory cascade [13]. A bar chart is given to illus-
trate the anti-inflammation effect of the alkaloid extract
of CB in Fig. 2. The results indicate that the swelling
volume increased progressively and peaked at 3rd hour
after carrageenin injection. However, the edema of rat
paw was significantly reduced by the treatment with the
high-dose alkaloid extract of CB (60 mg/kg) during all
phases of carrageenan-induced inflammation. And the
inhibition ratios of the CB (60 mg/kg) treatment with
rats at 0.5, 1 and 3 h were 29.8 % (P < 0.05), 28.3 % (P <
0.05) and 28.6 % (P < 0.01), respectively, compared to
the model control. Aspirin was used as a positive control
and had similar effects (31.9, 32.5 and 30.0 % inhib-
ition, respectively).
HPLC analysis for the alkaloid extract of CB
First, we established the fingerprint of the alkaloid ex-
tract of CB as the background information of macro-
phage binding. There were ten main peaks in the
fingerprint of the alkaloid extract of CB at 289 nm
(Fig. 3). Among these, five components were determined
after comparison with standards (Table 1). All of the
main peaks had good separation.
Injection precision was determined by five replicate in-
jections of the same sample in one day. The relative stand-
ard deviations (RSDs) of relative retention time (RRT) and
relative peak area (RPA) were 0.72 and 0.56 %, respect-
ively, and the changes were not significant. Repeatability
was assessed by analyzing five independently prepared
samples of the alkaloid extract of CB. RSDs of RRT and
RPA were 1.22, 1.57 %, respectively, and the changes were
not significant. Sample stability was assessed by successive
injections of the same sample at 0, 1, 2, 4, 8, 12 and 24 h.
During this period, the solution was stored at room
temperature. RSDs of RRT and RPA were 1.72 and 2.05 %,
respectively, and the changes were not significant. Results
of injection precision, repeatability and the stability test
suggested that this method was adequate, valid and applic-
able. RRT and RPA of each characteristic principle was
calculated using corynoline as the reference peak. The
RRT and RPA of the ten peaks are shown in Table 1.
Binding of the alkaloid extract of CB to RAW 264.7 cells
The alkaloid extract of CB exerted anti-inflammatory
properties, so we used its binding to RAW 264.7 cells to
screen the active compounds within it. The alkaloid ex-
tract of CB was incubated with RAW 264.7 cells and
bound components collected by centrifugation. After
thoroughly washing and eluting from cell pellets, retained
components were injected into HPLC system for analysis.
Two principal peaks (K-1 and K-2) were detected in
sample B (desorption eluate of the alkaloid extract of
CB) (Fig. 4a). No comparable peaks were detected in the
chromatograms of the two control samples (sample A,
Fig. 4 Detection of RAW 264.7 cells-binding molecules in the alkaloid extract of CB by HPLC analysis. a Comparative chromatograms of the
desorption eluate of alkaloid extract of CB. b the fingerprint of the alkaloid extract of CB. c the final wash eluate and d the vehicle desorption
eluate. Detection was at 289 nm
Table 1 RRT and the RPA of each peak in the fingerprint of the
alkaloid extract of CB
Peak number RRT RPA Identified compound
1 1.370 47.444 unknown
2 1.297 19.862 unknown
3 1.264 2.367 Protopine
4 1.152 15.868 unknown
5 1.139 6.923 12-hydmxycorynoline
6 1.046 2.849 6-acetonylcorynoline
7 1.000 1.000 Corynoline
8 0.953 21.822 Acetylcorynoline
9 0.933 3.622 unknown
10 0.892 75.680 unknown
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final wash eluate; sample C, vehicle desorption eluate)
(Fig. 4c and d). By comparison of the retention times
and UV absorption profiles of K-1 and K-2 with the
HPLC fingerprint of the alkaloid extract of CB, compo-
nents K-1 and K-2 were identified as peaks 2 and 3
(Fig. 4b). These findings identified the RAW 264.7 cell-
binding molecules K-1 and K-2 as potential anti-
inflammatory components of CB.
Identification of K-1 and K-2 by HPLC–MS
5 mg of K1 and K2 were respectively dissolved in d6-
CDCl3 as the samples, and detected by Bruker AV-500.
Fig. 5 ESI-MS negative ionization spectrum of K-2 obtained from macrophage binding
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The MS spectrum of compound K-2 is shown in Fig. 5.
The mass spectrum of compound K-2 was similar to
the mass spectrum of 12-hydoxycorynoline. Identifica-
tion was supported further by 1H-NMR data and 13C-
NMR data: 1HNMR (500 MHz, CDCl3): 6.661 (1H, s,
1-H), 7.023 (1H, s, 4-H), 2.177 (3H, s, 5-N-CH3), 3.437,
4.020 (2H, ABq, J = 15.5, 6-H), 6.808 (1H, d, J = 8.0, 9-
H), 6.962 (1H, d, J = 8.0, 10-H), 3.878 (1H, s, 11-H),
4.902 (1H, s, 12-H), 1.242 (3H, s, 13-CH3), 3.310 (1H,
s, 14-H), 5.995 ~ 5.942 (4H, m, 2-O-CH2-O-3, 7-O-
CH2-O-8); 13C-NMR (125 MHz, CDCl3): 107.8 (C-1),
125.9 (C-1a), 145.1 (C-2), 147.0 (C-3), 112.0 (C-4),
128.8 (C-4a), 43.1 (5-N-CH3), 54.0 (C-6), 116.3 (C-6a),
142.7 (C-7), 148.6 (C-8), 109.9 (C-9), 118.9 (C-10),
135.5 (C-10a), 74.0 (C-11), 81.4 (C-12), 39.7 (C-13),
23.7 (13-CH3), 70.2 (C-14), 101.4 (2-O-CH2-O-3),
101.4 (9-O-CH2-O-10).
Compound K-1 was postulated to be corynoline. Under
identical chromatographic conditions, the minor polar
compounds of K-1 and the retention time of the reference
peak of corynoline were identical.
Anti-inflammatory activity of corynoline and
12-hydroxycorynoline in vitro
ELISA assay was applied to examine the effect of cory-
noline and 12-hydroxycorynoline on IL-6, TNF-α, IL-10
and NO levels in LPS-treated cells. As showed in Figs. 6
and 7, LPS alone dramatically increased the levels of
IL-6, TNF-α, IL-10 and NO. However, corynoline or
12-hydroxycorynoline at the certain concentrations ob-
viously inhibited LPS-induced IL-6 and TNF-α over-
production. (P < 0.01 or P < 0.05). Corynoline (100 μg/
mL) significantly suppressed LPS-induced IL-10 over-
production (P < 0.05) while 12-hydroxycorynoline had
no obvious effect on this index (Fig. 7a). In addtion,
Corynoline (1, 100 μg/mL) and 12-hydroxycorynoline
(100 μg/mL) significantly inhibited LPS-induced NO
production (Fig. 7b).
Fig. 6 Anti-inflammatory effect of corynoline and 12-hydroxycorynoline on the level of IL-6 (a) a nd TNF-α (b) induced by LPS in RAW 264.7 cells.
Data are expressed as mean ± SD (n = 10). *p < 0.05 and **p < 0.01 vs. model group
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Discussion
CB, a perennial herb, has been shown to possess multiple
biological activities, such as anti-bacterial and anti-viral.
Its extract contains abundant alkaloids which are respon-
sible for the potential pharmacological activity and been
used as heat-clearing and detoxifying agent. However,
there is little knowledge about the anti-inflammatory ac-
tivity and the potential anti-inflammation components. In
the present study, we used aspirin as positive anti-
inflammatory compound because it is recognized as anti-
pyretic analgesics. Compared with it, we found that the
total alkaloids of CB have a significant anti-inflammatory
activity in vitro and in vivo. More importantly, com-
pounds K-1 and K-2 bound to macrophages which have
been identified as 12-hydmxycorynoline and corynoline
can inhibit LPS-induced inflammatory responses in RAW
264.7 cells.
The interesting and significant efficacy of herbs or TCM
has aroused the increasing interest of many researchers.
However, existing research is very difficult due to its
complex components. The active ingredient in Chinese
medicine and herbal medicine has been the focus of re-
search. Cells membrane chromatography (CMC), a chro-
matographic biological affinity method that uses specific
cell membranes as the stationary phase, has been con-
firmed as a simple, specific, effective screening method
based on the binding principle that the recognition
and interaction of drug molecules and targets, recep-
tors, channels on the cell membrane [14]. A novel peri-
toneal macrophage/cell membrane chromatography
(PM/CMC)-HPLC/MS method was shown to be an
effective screening system for the rapid detection,
enrichment, and identification of anti-inflammatory
components from TCM [14]. Herein, we carried
out this effective screening method to screen anti-
inflammatory components from CB. The structure
identification by spectral and chromatographic tech-
niques provided the evidence that corynoline and 12-
hydmxycorynoline are the binding components to
RAW 264.7 cells. Their anti-inflammatory activities
Fig. 7 Anti-inflammatory effect of corynoline and 12-hydroxycorynoline on the level of IL-10 (a) and NO (b) induced by LPS in RAW 264.7 cells.
Data are expressed as mean ± SD (n = 10). *p < 0.05 and **p < 0.01 vs. model group
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were proved in our study. This study supported the no-
tion that the binding of RAW 264.7 cells combined
with HPLC provides a rapid and efficient method for
the identification of potential anti-inflammatory com-
ponents in complex mixtures derived from medicinal
herbs used in TCM.
Endotoxin LPS are the major molecular component of
the outer membrane of Gram-negative bacteria and may
excite the local inflammatory response [15]. The inhib-
ition of LPS-induced pro-inflammatory cytokines from
macrophages can be archived by LPS immobilization on
porous and non-porous [16]. The stimulation of LPS
could cause inflammatory response and regulate the
release of inflammatory mediators. The potential inhib-
ition of components on LPS-induced inflammatory re-
sponse has been used to evaluate the anti-inflammatory
activity.
Corynoline is the major alkaloid component derived
from CB. Corynoline, acetylcorynoline, and protopine
can significantly reduce CCl4-induced microsomal lipid
peroxidation and attenuates 2,4-dinitro-1-fluoroben-
zene-induced delayed-type hypersensitivity. Some isoqui-
noline alkaloids such as 12-hydroxycorynoline isolated
from CB hold potential bacteriostatic activity. LPS stim-
ulates innate immunity by regulating the production of
inflammatory mediators such as NO, TNF-α, IL-6, pros-
tanoids, and leukotrienes [17]. For example, IL-6 overex-
pression is involved in rheumatoid arthritis [18]. TNF-α
exhibits its pro-inflammatory activity by regulating sev-
eral intercellular and vascular cell adhesion molecules,
which results in the recruitment of leukocytes to inflam-
mation sites [19]. In vitro bioassays have demonstrated
that corynoline and 12-hydroxycorynoline in CB signifi-
cantly inhibit the production of certain inflammatory
mediators, especially TNF-α and IL-6. It has been sug-
gested that corynoline and 12-hydroxycorynoline con-
tribute to the anti-inflammatory effects of CB.
Overall, the present study demonstrated the efficacy of
the alkaloid extract of CB in different anti-inflammatory
tests. Our established screening system showed that 12-
hydroxycorynoline and corynoline were two important
active components for the inhibition of LPS-stimulated
inflammatory responses. The anti-inflammatory effects
of CB might be due at least in part to the corynoline
and 12-hydroxycorynoline present in the plant. These
two compounds might be regarded as potential candi-
date molecules for inflammation inhibitors.
Conclusions
Our experimental results indicated that corynoline
and 12-hydroxycorynoline contribute to the anti-
inflammatory effects of the alkaloid extract of CB. Our
findings also suggested that these two compounds can
be used as candidate for anti-inflammatory drugs.
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